Correction:Occurrence of Leukaemia Following Gene Therapy of X-Linked SCID

Nature Reviews Cancer - United Kingdom
doi 10.1038/nrc1236
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)

Blood
BiochemistryImmunologyCell BiologyHematology
2016English

Gene Therapy for X-Linked Chronic Granulomatous Disease (Net4CGD)

Human gene therapy. Clinical development
Genetics
2015English

Selective Growth Advantage of Wild-Type Lymphocytes in X-Linked SCID Recipients

Bone Marrow Transplantation
TransplantationHematology
2002English

Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

333. Targeted Repair of IL2Rγ Locus in Vitro in Murine Model of X-Linked SCID

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

288. Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatous Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Child in Gene Therapy Programme Develops Leukaemia

BMJ
2008English

Two Unique Cases of X-Linked SCID: A Diagnostic Challenge in the Era of Newborn Screening

Frontiers in Pediatrics
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy